New 2023 NIS-Teen (National Immunization Survey - Teen) vaccination data were recently released. Read the CDC MMWR Report and check out the data on the interactive TeenVaxView tool. In this article, we'll give a brief breakdown of the HPV, MenACWY, and Tdap vaccination rates for Kansas and show where we're at now compared to previous years, the U.S., and our targets.
This data (and more!) are also available on the IKC Data Dashboard.
In summary, Kansas mirrored national data for adolescents age 13-17 years, holding mostly steady with mixed results by antigen. See additional details below. Most increases and decreases observed were not statistically significant. Above all, the data demonstrates that there is still work to do in all areas, particularly related to HPV vaccines. We will continue to monitor trends and work together to promote vaccines in Kansas!
The following graphs and estimates summarize changes without speaking to statistical significance.
See CDC's TeenVaxView for additional data on other states, sample sizes, and confidence intervals for estimates.
2023 Compared to 2022 NIS-Teen Estimates:
In the below summaries, fonts are color-coded as follows regarding changes from 2022 to 2023 data:
Note: Color coding does not speak to statistical significance.
Right direction
Mostly level, with slight movement in the wrong direction
Wrong direction
Tdap 2023 Compared to 2022 NIS-Teen Estimates:
Additional vaccine antigen data is available on TeenVaxView: HepA, HepB, MMR, and Varicella.
IKC's Data Dashboard is your go-to source for the latest Kansas immunization data, compiled and linked all in one place.
Thank you again to everyone who continues to work to improve adolescent immunization rates in Kansas!
Together, we will ensure Kansans teens are protected from HPV, meningitis, tetanus, and other vaccine-preventable diesease.
© 2015 -
Immunize Kansas Coalition is an independent 501(c)(3) non profit organization.
| © 2015 -Immunize Kansas Coalition is an independent 501(c)(3) non profit organization.
Supported by the Centers for Disease Control and Prevention (CDC) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $79,278,482 with 100% funded by the CDC/HHS.
The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, the CDC/HHS, the U.S. Government, or the Office of the Kansas Governor. For more information, please visit https://www.cdc.gov. [revision 10/01/21].